DrugPatentWatch Database Preview
Tedizolid phosphate - Generic Drug Details
» See Plans and Pricing
What are the generic sources for tedizolid phosphate and what is the scope of patent protection?
Tedizolid phosphate
is the generic ingredient in one branded drug marketed by Cubist Pharms Llc and is included in two NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Tedizolid phosphate has seventy-seven patent family members in thirty-nine countries.
One supplier is listed for this compound.
Summary for tedizolid phosphate
International Patents: | 77 |
US Patents: | 7 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 2 |
Suppliers / Packagers: | 1 |
Bulk Api Vendors: | 44 |
Clinical Trials: | 13 |
Patent Applications: | 96 |
DailyMed Link: | tedizolid phosphate at DailyMed |
Recent Clinical Trials for tedizolid phosphate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Merck Sharp & Dohme Corp. | Phase 3 |
Los Angeles Biomedical Research Institute | Phase 2 |
University of Southern California | Phase 4 |
Pharmacology for tedizolid phosphate
Drug Class | Oxazolidinone Antibacterial |
Mechanism of Action | Breast Cancer Resistance Protein Inhibitors |
US Patents and Regulatory Information for tedizolid phosphate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cubist Pharms Llc | SIVEXTRO | tedizolid phosphate | TABLET;ORAL | 205435-001 | Jun 20, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
Cubist Pharms Llc | SIVEXTRO | tedizolid phosphate | POWDER;INTRAVENOUS | 205436-001 | Jun 20, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Cubist Pharms Llc | SIVEXTRO | tedizolid phosphate | TABLET;ORAL | 205435-001 | Jun 20, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Cubist Pharms Llc | SIVEXTRO | tedizolid phosphate | TABLET;ORAL | 205435-001 | Jun 20, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
Cubist Pharms Llc | SIVEXTRO | tedizolid phosphate | TABLET;ORAL | 205435-001 | Jun 20, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for tedizolid phosphate
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 102516238 | Start Trial |
Costa Rica | 20110464 | Start Trial |
China | 102439006 | Start Trial |
South Korea | 20110120311 | Start Trial |
Russian Federation | 2006125761 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for tedizolid phosphate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1699784 | 1590047-5 | Sweden | Start Trial | PRODUCT NAME: TEDIZOLID, OPTIONALLY IN THE FORM OF AN ESTER, IN PARTICULAR A PHOSPHATE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/15/991 20150325 |
1699784 | 15C0062 | France | Start Trial | PRODUCT NAME: TEDIZOLIDE,EVENTUELLEMENT SOUS LA FORME D'UN ESTER ,EN PARTICULIER UN PHOSPHATE,OU L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/15/991 20150325 |
1699784 | 132016000024232 | Italy | Start Trial | PRODUCT NAME: TEDIZOLID, FACOLTATIVAMENTE IN FORMA DI ESTERE, IN PARTICOLARE UN FOSFATO, O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE(SIVEXTRO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/15/991/001, 20150325 |
1699784 | C01699784/01 | Switzerland | Start Trial | PRODUCT NAME: TEDIZOLID; REGISTRATION NO/DATE: SWISSMEDIC 65270 05.01.2016 |
1699784 | PA2015032,C1699784 | Lithuania | Start Trial | PRODUCT NAME: TEDIZOLIDAS, PASIRINKTINAI ESTERIO PAVIDALU, YPAC FOSFATO ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/15/991 20150323 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.